Follow
Herantis Pharma Oyj
Nasdaq First North Sweden (Sweden)
Nasdaq First North Finland (Finland)
Herantis Pharma PLC is a pharmaceutical drug development company. It focused on developing regenerative medicine for unmet clinical needs. The products of the group are CDNF for Parkinson's disease, Lymfactin for secondary lymphedema, CDNF for Amyotrophic lateral sclerosis and CDNF for other neurodegenerative diseases. The corporation is based in Finland.
Sector:
HEALTH CARE
>
Biotechnology
Sector:
TECHNOLOGY
News
Nothing to display for this company
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
Nasdaq First North Sweden
Sweden (SE)
Details of share in Herantis Pharma Oyj with ticker
Status
Active
Order book id
Amount of instruments
Par value
Market cap
Currency
Terms
This share is the same as the one listed on First North Finland with ISIN FI4000087861.
Type
Price
Pre-money valuation
Time
Listing
-
-
Oct 2019
Direct listing of Herantis Pharma Oyj on Nasdaq First North Sweden
Market
Nasdaq First North Sweden
Status
Upcoming
Comment for Listing
Herantis Pharma is listed on First North Finland. In May 2019 the company said that they will also get listed on First North Sweden during 2019.
Type
Ticker
ISIN
Market
SHARE
HRTIS
FI4000087861
Nasdaq First North Finland
Finland (FI)
Details of share in Herantis Pharma Oyj with ticker HRTIS
Status
Active
Order book id
Amount of instruments
6 062 287
Par value
Market cap
Currency
EUR
Segment
Regular
Terms
People
Number of Employees
10 people
Pekka Ilmari Simula
CEO
Pekka Allan Antero Mattila
Chairman of the board
Pekka Allan Antero Mattila
Board member
James Neil Phillips
Board member
Timo Ilari Veromaa
Board member
Frans Gustaf Wuite
Board member
Company Details
Sector
HEALTH CARE, TECHNOLOGY

Address
Bertel Jungin Aukio 1
Zip code
FI-02600
City/district
ESPOO
Country
Finland (FI)
Registration number
2198665-7
LEI code
743700W4CQVYAT3WKK38
First trade date
11 Jun 2014
Registration date
26 May 2008
Short name
Herantis Pharma